Skip to main content

Table 3 Clinical and histopathological data for the patients evaluated in this study

From: High prevalence of antinuclear antibodies in patients with chronic hepatitis C virus infection

Clinical characteristic

ANA-positive

ANA-negative

p-value

Systemic arterial hypertension

8 (44.4%)

24 (35.8%)

0.1243Q

Diabetes mellitus 2

2 (11.1%)

13 (19.4%)

0.5093E

Hepatomegaly

0

11 (16.4%)

0.1100E

Hepatic steatosis

5 (31.2%)

11 (17.2%)

0.1278Q

Cirrhosis

6 (33.3%)

9 (12.7%)

0.0708Q

Necroinflammatory activityG

 A0

1 (8.33%)

4 (7.55%)

0.6820

 A1

7 (58.33%)

27 (50.94%)

 A2

4 (33.3%)

18 (33.96%)

 A3

0

4 (7.55%)

Degree of fibrosisG

 F0

0

4 (7.55%)

0.0770

 F1

2 (16.67%)

20 (37.73%)

 F2

3 (25%)

16 (30.18%)

 F3

4 (33.3%)

12 (22.64%)

 F4

3 (25%)

1 (1.89%)

  1. QChi-square test; EFisher's exact test; GG test